King County stated that a a female resident in her late 30’s had died from the “very rare” complication. The unnamed resident received her J&J shot on August 26.
A county in Washington on Tuesday confirmed that a woman died from blood-clotting complications after receiving Johnson & Johnson’s single-dose COVID-19 vaccine. She is believed to be the fourth person to have died from such a complication.
King County stated that a female resident in her late 30s had died from the “very rare” complication. The unnamed resident received her J&J shot Aug. 26.
“Her cause of death was determined to be thrombosis with thrombocytopenia syndrome (TTS), a condition that has been identified as a rare but potentially serious adverse event in people who received the J&J vaccine,” the county said in a statement.
It’s the first study of individualized brain stimulation to treat severe depression. Sarah’s case raises the possibility the method may help people who don’t respond to other therapies.
I hope we get the hologram interfaces depicted too.
It’s becoming clear that aging is just as curable as other diseases such as the cold or a broken bone. Advancements in biotechnology now allow for targeted gene therapy and supplements to be invented that can both stop aging and even reverse the aging process through new Longevity Technology. The field of Longevity has expanded and evolved a lot during the past few years and have invented new treatments for diseases of old people which could increase the average lifespan of people by a ton according to the leading scientists such as David Sinclair and Aubrey De Grey. Anti Aging Supplements such as Metformin and NAD+, NMN are just the start. – Every day is a day closer to the Technological Singularity. Experience Robots learning to walk & think, humans flying to Mars and us finally merging with technology itself. And as all of that happens, we at AI News cover the absolute cutting edge best technology inventions of Humanity.
If you enjoyed this video, please consider rating this video and subscribing to our channel for more frequent uploads. Thank you! smile – TIMESTAMPS: 00:00 A new Benchmark in Longevity. 01:04 Living longer lives today. 03:13 How Genomics will extend our lifespans. 05:19 What are the societal concerns? 07:58 Last Words. – #longevity #immortality #treatment
Yezo virus, new disease that infects humans, discovered in japan.
Scientists have isolated a new orthonairovirus from two patients showing acute febrile illness with thrombocytopenia and leukopenia after tick bite in Hokkaido, Japan.
They cause sometimes fatal febrile illnesses in humans and other animals.
The availability of data can paralyze a company and its effort to bring software-centric products and services to market. To solve this issue, two-year-old data startup Rendered.ai is generating synthetic data for the satellite, medical, robotics and automotive industries.
At its most broad, synthetic data is manufactured rather than gathered from the real world. “When we use the term synthetic data what we really mean is engineered simulated datasets, and in particular, we focus on a physics-based simulation,” Rendered.ai CEO Nathan Kundtz explained in a recent interview with TechCrunch.
Kundtz received his PhD in physics from Duke University and cut his teeth in the space industry, heading the satellite antenna developer Kymeta Corporation. After leaving that company, he started working with other small space companies, when he noticed what he called a “chicken and egg” problem.
Driving this revolution has been a new breed and wave of founders and startups that merge the worlds of technology and bio — importantly, not just the old world of biotech (or a narrow definition of tech in bio as only “digital health”), but something much broader, bigger, and blending both worlds. In short, biology — enabled by technology — is eating the world. This has not only changed how we diagnose, treat, and manage disease, but has been changing the way we access, pay for, and deliver care in the healthcare system. It is now entering into manufacturing, food, and several other industries as well. Bio is becoming a part of everything.
This new era of industrialized bio — enabled by AI as well as an ongoing, foundational shift in biology from empirical science to more engineered approaches — will be the next industrial revolution in human history. And propelling it forward is an enormous new driving force, the novel coronavirus SARS-CoV-2, its ever-evolving strains, and the resulting COVID-19 disease pandemic and response — which I believe is analogous to our generation’s World War II (WW2). In other words: a massive global upheaval, but that later led to unprecedented innovation and significant new players.
As a result, we will now see the emergence of bio’s version of GAFA — playing off the “Google Amazon Facebook Apple” of the leading companies in computing, social, mobile — but for bio. And with it, a post-WW2/ post-Covid “Industrial Bio Complex”.
Although the idea of having a small device implanted in our skulls might sound terrifying to some, deep brain stimulation has had a successful past in other brain disorders such as Parkinson’s disease and epilepsy.
Depression can be a frighteningly relentless condition. Luckily, researchers around the world are constantly working on new treatment options, such as a newly designed brain implant for resistant depression.
Altogether, up to a third of people with depression don’t respond or become resistant to treatment. No medication or therapy type seems to help. For those with such treatment-resistant depression, the future can look especially bleak.
This is what happened to Sarah, a 36-year-old woman who’s had severe and treatment-resistant depression since she was a child. But a new proof-of-concept intervention has provided significant relief for Sarah, and could offer hope for many like her. The only catch? It requires a custom-designed ‘brain pacemaker’ for each person.
AstraZeneca said on Tuesday that it had asked the Food and Drug Administration to grant emergency authorization for an antibody treatment to prevent Covid-19 in people who are at high risk of the disease. If authorized, it would become the first such preventive treatment to be available in the United States, the company said.
The company said in a statement that the treatment had reduced the risk of symptomatic Covid-19 by 77 percent in a trial in which most participants either had other medical conditions that placed them at greater risk of severe illness or were not producing sufficient antibodies after vaccination.
It said the treatment could be used in conjunction with vaccines in people with weaker immune systems. Other antibody treatments in use in the United States, including one developed by the drug maker Regeneron, have mainly been used to treat people who are already infected with the coronavirus.
“To slow the ongoing loss of animal and plant life in the United States, President Biden signed an executive order in January 2,021 stating his administration’s goal to conserve 30% of U.S. lands and water by 2030. This bold, science-based initiative – America the Beautiful – is the first ever nationwide conservation effort to address both climate change and biodiversity loss.” https://www.futuretimeline.net/images/robot-future-timeline.jpg
The U.S. Fish and Wildlife Service (USFWS) has declared 23 species extinct, due to a combination of development, invasive species, logging and pollution.
The agency is recommending that the species be removed from the Endangered Species Act (ESA), the primary law in the United States for protecting and recovering imperilled organisms and the ecosystems they depend on. For the animals proposed for delisting, the protections of the ESA came too late.
These extinctions highlight the importance of the ESA and efforts to conserve species before declines become irreversible. The circumstances of each also underscore how human activity can drive population decline and ultimately extinction, by contributing to habitat loss, overuse and the introduction of invasive species and diseases. The growing impacts of climate change are anticipated to further exacerbate these threats and their interactions.
Comprehensive health, social services and economic well-being for american indian and alaska native elders — larry curley, executive director, national indian council on aging.
Mr. Curley is a member of the Navajo Nation with over 40 years of experience working in the aging and healthcare fields. He has worked with Congress, other branches of the federal government, and national organizations on aging to develop support for programs affecting elder American Indians.
After receiving his master’s degree in public administration at the University of Arizona, along with a certificate in gerontology, Mr. Curley worked as a gerontological planner at an Area Agency on Aging in Pima County, Arizona, where he was instrumental in establishing a county public fiduciary program. As a lobbyist in Washington, D.C., he successfully advocated for the passage of Title VI of the Older Americans Act, an amendment which he wrote.
Mr. Curley directed the Navajo Nation’s Head Start program, one of the five largest Head Start programs in the country, and has served as a nursing home administrator of a tribal, long-term care facility, a hospital administrator in northern Nevada, and as a college instructor at the University of Nevada-Reno and Eastern Washington University.
Mr. Curley was named as the assistant dean of the Four Corners region for the Burrell College of Osteopathic Medicine. He’s also served as the public representative on the American College of Physicians Clinical Guidelines Committee, and as the director of program development for the Rehoboth McKinley Christian Health Care Services in northwest New Mexico.
